@freesfund
Across every stage of preclinical drug R&D, new infrastructure, methods, and tools are emerging in China — making rapid, low-cost experimentation possible.
We've also released three short videos this issue — follow us to check them out.
Are New Materials Really Just a Gimmick?
Where are the opportunities in Metaverse development right now?
What Is the Metaverse? Where Did It Come From? Where Is It Going?
Why "Spring" Remains Elusive for SaaS, and the Root of US-China Startup Differences
Welcome to the team.
We also released two short videos this week — follow us to check them out.
New Trends in Consumption: From "Value for Money" to "Premium Pricing"
How does a D2C minimalist skincare brand break through?
